Infinity Bio is a technology company that provides detailed insights into the immune system using its proprietary antibody profiling platform. The company’s core technology comprehensively measures the antibody reactome, revealing the targets of individual immune responses against all known human viruses, human proteins (autoimmunity), and allergen proteins. Infinity's assay, MIPSA, was developed at Johns Hopkins University in Ben Larman's Lab of Precision Immunology. It builds off decades of work in the fields of genomics, proteomics, immunology, and bioinformatics. Our assay was engineered to enable best-in-class turnaround times and cost. With a team of experienced professionals and a state-of-the-art facility, we are poised to make a significant impact to research and for our customers.
Company Details
- Employees
- 25
- Founded
- -
- Address
- 6200 Seaforth St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.infinitybio.com
- Keywords
- Antibody, Immunology, Biotechnology, Services, Viruses, Allergens, Peptides, Proteomics, Autoimmune, Infectious Diseases, Vaccines.
- HQ
- Baltimore, Maryland
Infinity Bio, Inc. Questions
Infinity Bio, Inc.'s website is http://www.infinitybio.com
Infinity Bio, Inc.'s LinkedIn profile is https://www.linkedin.com/company/infinity-bio-inc
Infinity Bio, Inc. has
25 employees.
View email and phone details for 25
employees at Infinity Bio, Inc..
Infinity Bio, Inc.'s industry is
Biotechnology Research
Infinity Bio, Inc.'s top competitors are
Matterworks,
Biolinq,
Olaris, Inc,
Parallel Bio,
Arbor Biotechnologies,
Prellis Biologics,
Epicrispr Biotechnologies,
Cartesian Therapeutics,
Dispatch Bio,
Integerbio.
Infinity Bio, Inc.'s categories are Biotechnology Research
Infinity Bio, Inc.'s founding year is 2023
